Tiancong Wu

400 total citations
16 papers, 330 citations indexed

About

Tiancong Wu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Tiancong Wu has authored 16 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Tiancong Wu's work include Inflammasome and immune disorders (3 papers), Immune cells in cancer (3 papers) and Cancer Mechanisms and Therapy (2 papers). Tiancong Wu is often cited by papers focused on Inflammasome and immune disorders (3 papers), Immune cells in cancer (3 papers) and Cancer Mechanisms and Therapy (2 papers). Tiancong Wu collaborates with scholars based in China, United States and Spain. Tiancong Wu's co-authors include Wenjie Guo, Xixu Zhu, Ji Geng, Jing Gao, Wen Liu, Ting Fan, Qiang Xu, Wen Liu, Lijun Zhou and Zetian Shen and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Biochemical and Biophysical Research Communications.

In The Last Decade

Tiancong Wu

16 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tiancong Wu China 9 202 89 57 49 46 16 330
Niloufar Mohammadkhani Iran 9 190 0.9× 89 1.0× 100 1.8× 28 0.6× 29 0.6× 11 467
Hongping Wang China 13 251 1.2× 97 1.1× 51 0.9× 34 0.7× 37 0.8× 43 517
Molly M. Hood United States 9 128 0.6× 81 0.9× 78 1.4× 30 0.6× 46 1.0× 19 421
Hongmei Piao China 11 139 0.7× 113 1.3× 32 0.6× 25 0.5× 54 1.2× 18 365
Guangyi Gao China 11 208 1.0× 84 0.9× 89 1.6× 32 0.7× 24 0.5× 18 367
Haojie Du China 8 184 0.9× 71 0.8× 41 0.7× 38 0.8× 40 0.9× 19 446
M. V. Gazzola Italy 7 105 0.5× 68 0.8× 53 0.9× 41 0.8× 56 1.2× 10 441
Zi-Hao Wang China 14 186 0.9× 52 0.6× 48 0.8× 59 1.2× 48 1.0× 37 417

Countries citing papers authored by Tiancong Wu

Since Specialization
Citations

This map shows the geographic impact of Tiancong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiancong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiancong Wu more than expected).

Fields of papers citing papers by Tiancong Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiancong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiancong Wu. The network helps show where Tiancong Wu may publish in the future.

Co-authorship network of co-authors of Tiancong Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Tiancong Wu. A scholar is included among the top collaborators of Tiancong Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiancong Wu. Tiancong Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Xu, Lingyan, Yi Zou, Shushan Ge, et al.. (2024). IDO1 Inhibition Promotes Activation of Tumor-intrinsic STAT3 Pathway and Induces Adverse Tumor-protective Effects. The Journal of Immunology. 212(7). 1232–1243. 4 indexed citations
2.
Liu, Wen, Jia‐Shu Yang, Aihua Zhang, et al.. (2022). Spirodalesol analog 8A inhibits NLRP3 inflammasome activation and attenuates inflammatory disease by directly targeting adaptor protein ASC. Journal of Biological Chemistry. 298(12). 102696–102696. 18 indexed citations
3.
Wu, Tiancong, et al.. (2021). NLRP3 protects mice from radiation-induced colon and skin damage via attenuating cGAS-STING signaling. Toxicology and Applied Pharmacology. 418. 115495–115495. 26 indexed citations
4.
Li, Ao‐Mei, Han Zhou, Yangyang Xu, et al.. (2021). Role of thoracic radiotherapy in extensive stage small cell lung cancer: a systemic review and meta-analysis. Annals of Translational Medicine. 9(4). 299–299. 7 indexed citations
5.
Wu, Tiancong, et al.. (2021). Re-irradiation of multiple brain metastases using CyberKnife stereotactic radiotherapy. Medicine. 100(41). e27543–e27543. 3 indexed citations
6.
Wu, Tiancong, et al.. (2021). Radiation dosimetric influence by different target volume definition in Cyberknife lung cancer and abdomen stereotactic body radiotherapy. Journal of Radiation Research and Applied Sciences. 14(1). 336–343. 1 indexed citations
7.
Shen, Zetian, Ao‐Mei Li, Tiancong Wu, et al.. (2021). Metformin inhibits hepatocellular carcinoma development by inducing apoptosis and pyroptosis through regulating FOXO3. Aging. 13(18). 22120–22133. 44 indexed citations
8.
Li, Jing, Meng Zhang, Zetian Shen, et al.. (2020). Concurrent chemoradiotherapy with raltitrexed and nedaplatin regimen for esophageal squamous cell carcinoma. Medicine. 99(4). e18732–e18732. 3 indexed citations
9.
Wu, Tiancong, et al.. (2020). Pidotimod enhanced the anti-growth effect of cisplatin on lung cancer in mice via promoting anti-tumor immune response. Biochemical and Biophysical Research Communications. 528(4). 678–684. 3 indexed citations
10.
Wu, Tiancong, Wen Liu, Ting Fan, et al.. (2019). 5-Androstenediol prevents radiation injury in mice by promoting NF-κB signaling and inhibiting AIM2 inflammasome activation. Biomedicine & Pharmacotherapy. 121. 109597–109597. 28 indexed citations
11.
Liu, Wen, Tiancong Wu, Yue Hu, et al.. (2018). Carnosic acid enhances the anti-lung cancer effect of cisplatin by inhibiting myeloid-derived suppressor cells. Chinese Journal of Natural Medicines. 16(12). 907–915. 40 indexed citations
12.
Wu, Tiancong, Ji Geng, Wenjie Guo, Jing Gao, & Xixu Zhu. (2016). Asiatic acid inhibits lung cancer cell growth in vitro and in vivo by destroying mitochondria. Acta Pharmaceutica Sinica B. 7(1). 65–72. 74 indexed citations
13.
Wu, Tiancong, Wen Liu, Wenjie Guo, & Xixu Zhu. (2016). Silymarin suppressed lung cancer growth in mice via inhibiting myeloid-derived suppressor cells. Biomedicine & Pharmacotherapy. 81. 460–467. 29 indexed citations
14.
Hong, Zhu, Tiancong Wu, Lijun Zhou, et al.. (2013). Screening for differentially expressed genes between left- and right-sided colon carcinoma by microarray analysis. Oncology Letters. 6(2). 353–358. 18 indexed citations
15.
Hong, Zhu, Li Liu, Huan Liu, et al.. (2013). [Expression of galectin-7 and S100A9 and development of cervical squamous carcinoma].. PubMed. 38(9). 888–95. 3 indexed citations
16.
Zhu, Hong, Tiancong Wu, Lijun Zhou, et al.. (2012). Roles of galectin‐7 and S100A9 in cervical squamous carcinoma: Clinicopathological and in vitro evidence. International Journal of Cancer. 132(5). 1051–1059. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026